NCT01373606View on ClinicalTrials.gov

A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

December 31, 2009

Conditions
Hepatorenal Syndrome Type 1
Interventions
DRUG

Terlipressin

Trial Locations (2)

Unknown

Investigational site, Kansai

Investigational site, Kanto

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT01373606 - A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1 | Biotech Hunter | Biotech Hunter